<DOC>
	<DOCNO>NCT02141620</DOCNO>
	<brief_summary>This study determine initial efficacy , safety tolerability n-acetylcysteine pharmacotherapy cocaine dependence . A rigorous , inpatient human laboratory study conduct subjective , physiological reinforcing effect cocaine evaluate maintenance placebo n-acetylcysteine .</brief_summary>
	<brief_title>n-Acetylcysteine Cocaine</brief_title>
	<detailed_description />
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>Current cocaine use Current cigarette smoker Abnormal screening outcome ( e.g. , ECG , blood chemistry result ) study physician deem clinically significant Current past history substance abuse dependence deem study physician interfere study completion History serious physical disease , current physical disease , impair cardiovascular functioning , chronic obstructive pulmonary disease , history seizure current past history serious psychiatric disorder opinion study physician would interfere study participation exclude participation Females currently use effective birth control Contraindications cocaine nacetylcysteine History schizophrenia first degree relative</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>